Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | SARS-CoV-2 | Research article

COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities

Authors: Ibironke W. Apata, Jason Cobb, Jose Navarrete, John Burkart, Laura Plantinga, Janice P. Lea

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

Emory Dialysis serves an urban and predominantly African American population at its four outpatient dialysis facilities. We describe COVID-19 infection control measures implemented and clinical characteristics of patients with COVID-19 in the Emory Dialysis facilities.

Methods

Implementation of COVID-19 infection procedures commenced in February 2020. Subsequently, COVID-19 preparedness assessments were conducted at each facility. Patients with COVID-19 from March 1–May 31, 2020 were included; with a follow-up period spanning March–June 30, 2020. Percentages of patients diagnosed with COVID-19 were calculated, and characteristics of COVID-19 patients were summarized as medians or percentage. Baseline characteristics of all patients receiving care at Emory Dialysis (i.e. Emory general dialysis population) were presented as medians and percentages.

Results

Of 751 dialysis patients, 23 (3.1%) were diagnosed with COVID-19. The median age was 67.0 years and 13 patients (56.6%) were female. Eleven patients (47.8%) were residents of nursing homes. Nineteen patients (82.6%) required hospitalization and 6 patients (26.1%) died; the average number of days from a positive SARS-CoV-2 (COVID) test to death was 16.8 days (range 1–34). Two patients dialyzing at adjacent dialysis stations and a dialysis staff who cared for them, were diagnosed with COVID-19 in a time frame that may suggest transmission in the dialysis facility. In response, universal masking in the facility was implemented (prior to national guidelines recommending universal masking), infection control audits and re-trainings of PPE were also done to bolster infection control practices.

Conclusion

We successfully implemented recommended COVID-19 infection control measures aimed at mitigating the spread of SARS-CoV-2. Most of the patients with COVID-19 required hospitalizations. Dialysis facilities should remain vigilant and monitor for possible transmission of COVID-19 in the facility.
Literature
6.
go back to reference Watnick S, McNamara E. On the frontline of the COVID-19 outbreak: keeping patients on long-term Dialysis safe. Clin J Am Soc Nephrol. 2020;15(5):710–3.CrossRef Watnick S, McNamara E. On the frontline of the COVID-19 outbreak: keeping patients on long-term Dialysis safe. Clin J Am Soc Nephrol. 2020;15(5):710–3.CrossRef
7.
go back to reference Yiqiong Ma BD, Xifeng Lv, Jili Zhu, Wei Liang, Lei Liu, Wenduo Bu. 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD centers in Wuhan, China2020, medRxiv. Yiqiong Ma BD, Xifeng Lv, Jili Zhu, Wei Liang, Lei Liu, Wenduo Bu. 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD centers in Wuhan, China2020, medRxiv.
8.
go back to reference American Society of Nephrology. Information for screening and management of COVID-19 in the outpatinet dialysis facility. 2020. American Society of Nephrology. Information for screening and management of COVID-19 in the outpatinet dialysis facility. 2020.
9.
go back to reference Centers for Disease Control and Prevention. Interim additional guidance for infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in outpatient hemodialysis facilities. In:2020. Centers for Disease Control and Prevention. Interim additional guidance for infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in outpatient hemodialysis facilities. In:2020.
11.
go back to reference Kliger AS, Cozzolino M, Jha V, Harbert G, Ikizler TA. Managing the COVID-19 pandemic: international comparisons in dialysis patients. Kidney Int. 2020;98(1):12–6.CrossRef Kliger AS, Cozzolino M, Jha V, Harbert G, Ikizler TA. Managing the COVID-19 pandemic: international comparisons in dialysis patients. Kidney Int. 2020;98(1):12–6.CrossRef
13.
go back to reference Weiner DE, Watnick SG. Hemodialysis and COVID-19: an Achilles' heel in the pandemic health care response in the United States. Kidney Med. 2020;2(3):227–30. Weiner DE, Watnick SG. Hemodialysis and COVID-19: an Achilles' heel in the pandemic health care response in the United States. Kidney Med. 2020;2(3):227–30.
14.
go back to reference Corbett RW, Blakey S, Nitsch D, et al. Epidemiology of COVID-19 in an urban Dialysis center. J Am Soc Nephrol. 2020;31:1815–24. Corbett RW, Blakey S, Nitsch D, et al. Epidemiology of COVID-19 in an urban Dialysis center. J Am Soc Nephrol. 2020;31:1815–24.
15.
go back to reference La Milia V, Bacchini G, Bigi MC, et al. COVID-19 outbreak in a large hemodialysis center in Lombardy, Italy. Kidney Int Rep. 2020;5(7):1095–9.CrossRef La Milia V, Bacchini G, Bigi MC, et al. COVID-19 outbreak in a large hemodialysis center in Lombardy, Italy. Kidney Int Rep. 2020;5(7):1095–9.CrossRef
19.
go back to reference Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19. N Engl J Med. 2020;382(22):2158–60.CrossRef Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19. N Engl J Med. 2020;382(22):2158–60.CrossRef
20.
go back to reference Rodrigo E, Pinera VC, Setien MA, et al. Silent COVID-19 in haemodialysis facilities in Cantabria, Spain: an ecological study. Clin Kidney J. 2020;13(3):475–6.CrossRef Rodrigo E, Pinera VC, Setien MA, et al. Silent COVID-19 in haemodialysis facilities in Cantabria, Spain: an ecological study. Clin Kidney J. 2020;13(3):475–6.CrossRef
Metadata
Title
COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities
Authors
Ibironke W. Apata
Jason Cobb
Jose Navarrete
John Burkart
Laura Plantinga
Janice P. Lea
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02281-6

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.